Interplay between Oxidative Stress and Inflammation in Cardiometabolic Syndrome
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Around 50–60% of adults in western countries are either overweight or obese with more than 25% falling into the obese category [1]. The metabolic imbalance underlying obesity has fueled the prevalence of cardiometabolic syndrome—a constellation of interrelated risk factors of metabolic origins that together promote the increased risk of cardiovascular disease (CVD) and type II diabetes [2]. These are the major causes of morbidity, mortality, and sky-rocketing healthcare costs in industrialized countries. Obesity is the hallmark component of cardiometabolic syndrome with other key components being insulin resistance, hypertension, dyslipidemia, and endothelial dysfunction. While each of the associated conditions has an independent effect, their clustering has a synergistic effect, making the risk of developing cardiovascular disease greater. Obesity with the associated cardiometabolic syndrome components has a direct effect on atherogenic dyslipidemia, elevated blood pressure, and elevated plasma glucose and promotes proinflammatory and prothrombotic states. Cardiometabolic syndrome is associated with increased oxidative stress; however, the source of reactive oxygen species (ROS) and their exact targets are not well understood. Oxidation products of different organic molecules including lipids, proteins, and nucleic acids have been used to demonstrate the presence of oxidative stress in patients with cardiometabolic syndrome and CVD. Mitochondria have been shown to be a major source and target of reactive oxygen species in obesity-induced heart disease with consequences being impaired cardiac energetics, development of left ventricular hypertrophy, and diastolic dysfunction [3]. Angiotensin II-induced activation of NADPH oxidase also plays a role, with direct effects via redox posttranslational modifications of proteins within the caveolar compartment. The further downstream effects of ROS and redox regulation are mediated mostly by protein oxidative and nitrosative posttranslational modifications of proteins [4]. Cardiometabolic syndrome has also been associated with the presence of a number of inflammatory markers. Low-grade inflammation is a common manifestation and could play a role in the pathogenesis of obesity and cardiometabolic syndrome and its sequelae. Dysregulation of adipose tissue biology plays a potential role in the initiation of inflammatory events in obesity and cardiometabolic syndrome causing chronic inflammatory response characterized by abnormal adipokine production and the activation of several proinflammatory signaling pathways, resulting in the induction of several proinflammatory cytokines from adipose tissue that have been suggested to play a role in pathogenesis of CVD. Furthermore, the dysregulation adipose tissue biology, mediated by increased redox stress and inflammation, adversely affects angiogenesis both locally and systemically [5], further contributing to the global impact of cardiometabolic syndrome. It is important to remember that cardiometabolic syndrome frequently coexists with many other diseases, linked by its high prevalence as well as commonalities in aetiology or even causative contribution. A common nexus between many of these disease states is the presence of endothelial dysfunction, mediated either by decreased synthesis and enhanced clearance or by impaired bioaction of nitric oxide. Rheumatoid arthritis, a common autoimmune inflammatory connective tissue condition, has been associated with increased incidence of CVD. In this issue, T. Dimitroulas et al. investigated the relationship between levels of symmetric dimethylarginine (SDMA), an inactive congener of asymmetrical dimethylarginine, a marker and mediator of nitric oxide synthase inhibition, and inflammatory burden and CVD risk factors in a cohort of rheumatoid disease patients. Interestingly, the authors have not found such an association, potentially related to the interacting effects of antirheumatoid therapy, factors affecting kinetics of SDMA and potentially methodology for SDMA measurement. Chronic kidney disease is another condition that is intimately linked with incidence of cardiometabolic syndrome and CVD. Kidney disease can result from impaired cardiovascular function but also can in turn lead to worsening cardiac and vascular stiffening and fibrosis. A study by S. Rasic et al., in this issue, suggests that malondialdehyde (an oxidative stress marker) and matrix metalloproteinase-9 (a marker/mediator of fibrosis) are significant predictors of atherosclerosis in chronic kidney disease patients. A. Bakillah et al. looked at the levels of nitrosatively modified proteins in plasma of chronic kidney disease patients undergoing kidney transplantation and found a reduction in nitrated apolipoprotein A-I after transplantation, suggesting reduction in oxidative/nitrosative stress. In an animal model of cardiometabolic syndrome induced in rats by coca cola drinking M. Otero-Losada et a
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Park, Y.-W., Zhu, S., Palaniappan, L., Heshka, S., Carnethon, M. R., & Heymsfield, S. B. (2003) · Archives of Internal Medicine · doi:10.1001/archinte.163.4.427 · Cited by 2,074 · cited 1×
“The metabolic imbalance underlying obesity has fueled the prevalence of cardiometabolic syndrome— a constellation of interrelated risk factors ofmetabolic origins that together promote the increased risk of cardiovascular disease (CVD) and type II diabetes [2].”
BackgroundSverdlov, A. L., Elezaby, A., Qin, F., Behring, J. B., Luptak, I., Calamaras, T. D., Siwik, D. A., Miller, E. J., Liesa, M., Shirihai, O. S., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002555 · Cited by 128
Self-citationThomas, D. M., Weedermann, M., Fuemmeler, B. F., Martin, C. K., Dhurandhar, N. V., Bredlau, C., Heymsfield, S. B., Ravussin, E., & Bouchard, C. (2014) · Obesity · doi:10.1002/oby.20520 · Cited by 83
Ngo, D. T. M., Farb, M. G., Kikuchi, R., Karki, S., Tiwari, S., Bigornia, S. J., Bates, D. O., LaValley, M. P., Hamburg, N. M., Vita, J. A., et al. (2014) · Circulation · doi:10.1161/circulationaha.113.008171 · Cited by 81
Self-citationReversible Oxidative Modification: Implications for Cardiovascular Physiology and Pathophysiology
Rasmussen, H., Hamilton, E. J., Liu, C., & Figtree, G. A. (2010) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2010.06.002 · Cited by 50
Self-citation
Cited by
Mens, M. M. J., Harriman, N. W., Jopling, E., Hare, M., Drury, S. S., Roy, T. R., Hastings, W. J., Nelson, C. A., Zeanah, C. H., Fox, N. A., et al. (2026) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2026.107867
Metadata
- Authors
- Sverdlov, A. L., Figtree, G. A., Horowitz, J. D., & Ngo, D. T. M.
- Affiliations
- Boston University (US)
- The University of Sydney (AU)
- Basil Hetzel Institute (AU)
- Corresponding author
- Sverdlov, Aaron L.
- Venue
- Mediators of Inflammation
- Publisher
- Wiley
- Published
- 2016
- Volume
- 2016
- Pages
- 1-3
- ISSN
- 0962-9351 (ISSN-L)
- 1466-1861
- PMC
- PMC4985569
- OpenAlex
- W2483440377
- Cited by
- 40
- References
- 5
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 4 · 2023: 2 · 2022: 4 · 2021: 5 · 2020: 3 · 2019: 8 · 2018: 1
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Mediators of Inflammation (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Nitric Oxide and Endothelin Effects
- Health Sciences › Medicine › Biochemistry (medical) › Antioxidant Activity and Oxidative Stress
- Keywords
- cardiometabolic syndrome, oxidative stress, inflammation, obesity, reactive oxygen species, mitochondrial reactive oxygen species, NADPH oxidase, angiotensin II, nitrosative stress, adipose tissue inflammation, adipokines, inflammatory cytokines, angiogenesis, endothelial dysfunction, insulin resistance, cardiovascular disease, type 2 diabetes, dyslipidemia
- MeSH terms
- Blood Glucose, Blood Pressure, Cardiovascular Diseases, Diabetes Mellitus, Type 2, Humans, Inflammation, Insulin Resistance, Obesity, Risk Factors, Thrombosis, Oxidative Stress, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Interplay between Oxidative Stress and Inflammation in Cardiometabolic Syndrome. https://app.cochat.ai/papers/10.1155/2016/8254590
- The paper
- Sverdlov, A. L., Figtree, G. A., Horowitz, J. D., & Ngo, D. T. M. (2016). Interplay between Oxidative Stress and Inflammation in Cardiometabolic Syndrome. Mediators of Inflammation. https://doi.org/10.1155/2016/8254590
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.